SOLICITATION NOTICE
65 -- INFECTIOUS DISEASE TESTING
- Notice Date
- 5/9/2005
- Notice Type
- Solicitation Notice
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of the Air Force, Air Force Materiel Command, HSW - 311 Human Systems Wing, 311th HSW/PK 8150 Aeromedical Road, Brooks AFB, TX, 78235-5123
- ZIP Code
- 78235-5123
- Solicitation Number
- Reference-Number-F1JEAB5066B001
- Response Due
- 6/9/2005
- Archive Date
- 6/24/2005
- Description
- STATEMENT OF WORK IN SUPPORT OF AFIOH/SDE IMMUNOLOGY INFECTIOUS DISEASE TESTING 06 May 2005 1. DESCRIPTION OF SERVICES: The Contractor shall provide AFIOH/SDE (Epidemiological Surveillance Division), Bldg 930, Brooks City Base TX 78235-5132 with FDA approved reagents to perform infectious disease testing for the Immunology Reference Laboratory. 2. REQUIREMENTS: The Contractor shall provide to the Immunology Reference Laboratory reagents necessary to perform the following tests: Herpes Simplex Virus Type 1-Specific ELISA, Herpes Simplex Virus Type 2-Specific ELISA, Q Fever (Coxiella burnetii) IgM IFA, Rickettsia rickettsii IgM IFA, and Rickettsia typhi IgM IFA. All reagents must be FDA and CAP approved and should exhibit at least 95% sensitivity and 95% specificity. Upon request, sufficient reagents should be provided by the Contractor for in-house evaluation of each analyte. Following evaluation, each reagent should exhibit at least 90% agreement with reagents currently in use in the Immunology Reference Laboratory. The Contractor shall also include Calibrators, Controls and wash buffers sufficient to do the established volume of testing, at no additional cost. 3. ESTIMATED USAGE: There is no guaranteed minimum; however, the Immunology Laboratory performs an estimated 15,200 total tests per year for these infectious diseases listed below. Reagent Tests/Yr Herpes Simplex Virus Type-1-Specific 7,200 ELISA IgG Herpes Simplex Virus Type-2-Specific 7,200 ELISA IgG Rickettsia IgM Antibody Profile IFA 400 Q Fever (Coxiella burnetti) IgM IFA 400 Total: 15,200 Rickettsia Includes: Rickettsia rickettsii IgM IFA Rickettsia typhi IgM IFA 4. AGREEMENT PERIOD: A contract or Blanket Purchase Agreement (BPA) shall be set up for a period of one year and if exercised, one option year. The Government also reserves the right to discontinue services without incurring any additional costs, if there is a change in mission requirements or if the reagents fail to perform as described by the vendor. Should a change in mission/testing requirements occur, the Government will notify the vendor in writing 30 days prior to the proposed discontinuation of services. 5. POINTS OF CONTACT: Primary Technical Program Manager: Capt Jeannette Watterson, (210) 536-1672, FAX (210) 536 ?2638 Alternate Technical Program Manager: Sylvia Trevino, (210) 536-8727, FAX (210) 536- 2638 Program Manager: Ruben T. Sandoval, (210) 536-5790, FAX (210) 536-5877 6. LIABILITY: The Vendor will indemnify and defend the US Air Force from and against any and all third party claims, demands, actions, debts, liabilities, and attorney?s fees arising out of, claimed on account of, or in any manner predicated upon loss of, or damage to the property of, and injuries to, or death of any and all persons whatsoever, in any manner caused or contributed to by simple negligence or misconduct of the Vendor, use of its product, or negligent or willful wrongdoing by its agents, servants, or employees. EVALUATION CRITERIA FOR PROPOSALS IN SUPPORT OF AFIOH/SDE IMMUNOLOGY INFECTIOUS DISEASE TESTING 6 MAY 2005 The Contractor will provide a written proposal in response to the SOW. The Government anticipates awarding a ?best value? Blanket Purchase Agreement to the Contractor whose proposal is the most technically advantageous to the Government, while price and other factors will be considered as lesser factors than technical. Technical proposals will be evaluated on the factors described below, listed in order of importance. Technical merit is more significant than price. Each Contractor will be evaluated on the basis of products that efficiently and effectively respond to and successfully complete tasks defined in the SOW. 1. The contractor shall provide a broad testing menu capability as per paragraphs 2 and 3 of the Statement of Work (SOW) essential in performing infectious disease testing for the Immunology Reference Laboratory. 2.The contractor?s product must meet the Immunology Laboratory?s needs with respect to evaluation and interpretation, i.e., immunofluorescence slides must be of high enough quality and clarity to facilitate reading/interpretation. Also: a) Reagents must exhibit at least 90% agreement with reagents currently in use in the Immunology laboratory. b) Q Fever IgM slides requires differentiation between phase 1 and phase 2 (acute and convalescent distinction) . This criteria will be on a pass/fail evaluation. 3. Exceptional assay precision of 90% or greater will be on a pass/fail evaluation. 4. All reagents must be FDA and CAP approved and should exhibit at least 95% sensitivity and 95% specificity. 5. Herpes Simplex Virus 1 IgG ELISA and Herpes Simplex Virus 2 IgG ELISA must be type-specific tests as recommend by CDC (Center for Disease Control and Prevention) and AMA (American Medical Association). Cross-reactivity between HSV types 1 and 2 is not acceptable. This criteria will be on a pass/fail evaluation. 5. Greater consideration will be given to reagents, calibrators, and controls which require less preparation, i.e. ready to use. 6. The Contractor shall propose cost per test amount to include calibrators, controls and wash buffers for the annual average usage as per paragraph 3 of the SOW. More consideration will be given to the lower cost per test via the annual average usage.
- Place of Performance
- Address: BROOKS CITY BASE, TX
- Zip Code: 78155
- Zip Code: 78155
- Record
- SN00803240-W 20050511/050509211834 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |